Flavio Maina

15PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersTissue engineeringCancer geneticsGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 25, 2025
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.

Celia Sequera, Margherita Grattarola, Floriane Cannet

|Nov 26, 2022
MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities.

Celia Sequera, Margherita Grattarola, Agnes Holczbauer

|Mar 10, 2022
Enhanced Wild-Type MET Receptor Levels in Mouse Hepatocytes Attenuates Insulin-Mediated Signaling.

Patricia Rada, Fabienne Lamballe, Elena Carceller-López

|Mar 31, 2021
The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC.

Lohit Khera, Yaron Vinik, Flavio Maina

Pageof 3